ArticleJournal of cellular and molecular medicine2021

Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway.

Zhaodi Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.